NeOnc Technologies Holdings (NTHI) Revenue & Revenue Breakdown
NeOnc Technologies Holdings Revenue Highlights
Latest Revenue (Y)
$83.00K
NeOnc Technologies Holdings Revenue by Period
NeOnc Technologies Holdings Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $83.00K | 17.79% |
| 2023-12-31 | $70.46K | 252.31% |
| 2022-12-31 | $20.00K | 100.00% |
| 2021-12-31 | - | - |
NeOnc Technologies Holdings generated $83.00K in revenue during NA 2024, up 17.79% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
NeOnc Technologies Holdings Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $39.99K | 99.95% |
| 2024-12-31 | $20.00K | 100.00% |
| 2024-09-30 | - | -100.00% |
| 2024-06-30 | $20.00K | -53.49% |
| 2024-03-31 | $43.00K | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $35.23K | 76.16% |
| 2022-12-31 | $20.00K | 100.00% |
| 2022-09-30 | - | - |
NeOnc Technologies Holdings generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
NeOnc Technologies Holdings Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CDXS | Codexis | $59.34M | $8.60M |
| GNFT | Genfit | $28.57M | $17.08M |
| OABI | OmniAb | $26.39M | $2.24M |
| IVVD | Invivyd | $25.38M | $13.13M |
| MDWD | MediWound | $18.69M | $4.96M |
| IVA | Inventiva | $17.48M | $2.73M |
| OBIO | Orchestra BioMed | $2.64M | $861.00K |
| NTHI | NEONC TECHNOLOGIES | $83.00K | - |
| SLS | SELLAS Life Sciences Group | - | - |
| TARA | Protara Therapeutics | - | - |